Skip to main content
Erschienen in: Reactions Weekly 1/2015

01.04.2015 | Case report

Infliximab

Delayed hypersensitivity reaction and anaphylactic acute infusion reactions: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (FDA MedWatch definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * requires intervention to prevent permanent impairment or damage
Literatur
Zurück zum Zitat Brandse JF, et al. Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease. Inflammatory Bowel Diseases 20: 251-258, No. 2, Feb 2014 - NetherlandsCrossRefPubMed Brandse JF, et al. Effects of infliximab retreatment after consecutive discontinuation of infliximab and adalimumab in refractory Crohn's disease. Inflammatory Bowel Diseases 20: 251-258, No. 2, Feb 2014 - NetherlandsCrossRefPubMed
Metadaten
Titel
Infliximab
Delayed hypersensitivity reaction and anaphylactic acute infusion reactions: 3 case reports
Publikationsdatum
01.04.2015
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2015
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-015-9961-x

Weitere Artikel der Ausgabe 1/2015

Reactions Weekly 1/2015 Zur Ausgabe

Case report

Propranolol

Case report

Methylphenidate

Case report

Ropivacaine